EB2027
SAVE THE DATE
4ā6 November 2027 | Vienna, Austria
The EB2027 International Congress is Coming to Vienna!
From 4 to 6 November 2027, Vienna, Austria, will host a leading international congress dedicated to Epidermolysis Bullosa (EB), bringing together expertise in research, clinical care, patient leadership and infrastructure to strengthen collaboration and translate shared ideas into concrete actions.
The global EB community has reached a pivotal moment. Scientific breakthroughs, novel therapies and rapidly expanding knowledge are transforming what is possible for people living with Epidermolysis Bullosa.
Yet scientific excellence alone is no longer enough. Delivering meaningful patient benefit now depends on something different: our ability to work together. Across research, clinical care, patient advocacy, industry, regulators, policy makers and funders, remarkable expertise already exists. However, many activities remain fragmented, disconnected or duplicated. As the complexity of the EB landscape grows, so does the need for coordinated structures that enable collaboration, shared priorities and collective action.
EB2027 will be created to address exactly this challenge. Rather than another scientific meeting, it is designed as a strategic working conference where stakeholders jointly develop the foundations of a stronger international EB ecosystem.
Contact information
Dr. Anna Huber
Project Manager EB2027
anna.huber@debra-international.org